Liraglutide reduces attenuation coefficient as a measure of hepatic steatosis during 16 weeks' treatment in nondiabetic obese patients: A pilot trial

by Xiao Jing Wang, Ping Gong, Chenyun Zhou, Chengwu Huang, U‐Wai Lok, Shanshan Tang, Ann Taylor, Deborah Eckert, Shigao Chen, Michael Camilleri
Published 2021-02-01